American Journal of Physiology Heart and Circulatory Physiology · Nov 18, 2026
Higher serum complement component 1q is associated with lower physical fitness and greater cardiometabolic risk in Japanese adults
By Iwaguchi K, Nishikawa T, Kurose S et al.
Complement component 1q (C1q) has been implicated in age-related decline in tissue function; however, its association with physical fitness and cardiometabolic risk remains unclear. This observational, cross-sectional study examined the associations of serum C1q concentrations with physical fitness and cardiometabolic risk scores in 507 Japanese adults aged 18–88 years. Component z-scores were calculated within the four groups defined by sex and age. The physical fitness score averaged z-scores of peak oxygen uptake (V̇O₂peak) and absolute grip strength. The cardiometabolic risk score averaged z-scores for body fat percentage, mean arterial pressure, hemoglobin A1c, triglycerides, and sign-reversed high-density lipoprotein cholesterol. Participants with higher physical fitness scores had lower serum C1q levels and lower cardiometabolic risk scores, whereas participants with higher serum C1q levels had lower physical fitness scores and higher cardiometabolic risk scores. Partial correlations adjusted for age, sex, smoking status, and medication use showed that serum C1q levels were negatively associated with physical fitness score (r = −0.390) and positively associated with cardiometabolic risk score (r = 0.525). These associations were also observed in men, women, young adults, and middle-aged and older adults. Exploratory segmented regression with data-driven breakpoint estimation identified significant changes in slope for both C1q associations, suggesting departures from simple linear relationships. These findings suggest that the relationships of serum C1q levels with physical fitness and cardiometabolic risk may vary across the range of serum C1q levels. Serum C1q may therefore be a blood marker associated with lower physical fitness and increased cardiometabolic risk.
doi.org/10.1152/ajpheart.90162.2026PubMed 43046765Biomarkers